L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells.
Jung SA, Lee DH, Moon JH, Hong SW, Shin JS, Hwang IY, Shin YJ, Kim JH, Gong EY, Kim SM, Lee EY, Lee S, Kim JE, Kim KP, Hong YS, Lee JS, Jin DH, Kim T, Lee WJ.
Jung SA, et al. Among authors: lee dh, lee ey, lee js, lee s, lee wj.
Free Radic Biol Med. 2016 Jun;95:200-8. doi: 10.1016/j.freeradbiomed.2016.03.009. Epub 2016 Mar 22.
Free Radic Biol Med. 2016.
PMID: 27012422